Chinese consensus on therapeutic drug monitoring of targeted drugs for the treatment of gastrointestinal stromal tumors

Title: Chinese consensus on therapeutic drug monitoring of targeted drugs for the treatment of gastrointestinal stromal tumors
Edition: Original
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users: Doctors, pharmacists, nurses and laboratory technicians in various medical institutions involved in the treatment and management of gastrointestinal stromal tumors
Evidence classification method: GRADE
Development unit: Hospital Pharmacy Committee of Chinese Pharmaceutical Association; Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society; Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association;
Registration time: 2021-03-29
Registration number: IPGRP-2021CN075
Purpose of the guideline: To formulate the technical specifications of therapeutic drug monitoring for targeted drugs in the treatment of gastrointestinal stromal tumors including timing, frequency and indicators, as well as the interpretation of the results and the clinical application, guiding the individualized therapy and whole-course management of such patients